OVARIAN EPITHELIAL CANCER
Clinical trials for OVARIAN EPITHELIAL CANCER explained in plain language.
Never miss a new study
Get alerted when new OVARIAN EPITHELIAL CANCER trials appear
Sign up with your email to follow new studies for OVARIAN EPITHELIAL CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for rare cancers: immunotherapy drug targets tumors regardless of origin
Disease control Recruiting nowThis study tests the drug nivolumab in people with advanced rare cancers that have a specific marker (PD-L1). The goal is to see if the drug can shrink or control the tumors when other treatments have stopped working. Up to 28 adults will receive treatment for up to 12 months, an…
Matched conditions: OVARIAN EPITHELIAL CANCER
Phase: PHASE2 • Sponsor: Instituto do Cancer do Estado de São Paulo • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
New dye combo could spare ovarian cancer patients unnecessary surgery
Diagnosis Recruiting nowThis pilot study is testing whether a combination of two dyes (technetium-99m albumin nanocolloid and indocyanine green) can accurately identify the first lymph node where ovarian cancer might spread. The goal is to improve surgical staging and potentially avoid removing many lym…
Matched conditions: OVARIAN EPITHELIAL CANCER
Phase: NA • Sponsor: Fundacion Clinic per a la Recerca Biomédica • Aim: Diagnosis
Last updated Jun 27, 2026 09:03 UTC